BCM
THRD

Bridgeway Capital Management’s Third Harmonic Bio THRD Stock Holding History

Bridgeway Capital Management’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-45,000
Closed -$425K – 1343
2024
Q1 		$425K Hold
45,000
– – 0.01% 962
2023
Q4 		$494K Sell
45,000
-44,100
-49% -$349K 0.01% 948
2023
Q3 		$569K Hold
89,100
– – 0.01% 842
2023
Q2 		$429K Buy
89,100
+30,000
+51% +$143K 0.01% 948
2023
Q1 		$243K Buy
+59,100
New +$251K 0.01% 1065

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bridgeway Capital Management's THRD Position: Q2 2024 in Review

Bridgeway Capital Management sold out of Third Harmonic Bio (THRD) in Q2 2024, closing a stake of 45,000 shares — an estimated $425K sold.

Bridgeway Capital Management first reported a position in THRD in Q1 2023 and held it in 5 quarters. The position peaked at $569K in Q3 2023. 76 funds tracked by Wall St. Rank hold THRD as of Q2 2024.

  • Bridgeway Capital Management reported no remaining Third Harmonic Bio position as of Q2 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 45,000 Third Harmonic Bio shares in Q2 2024, an estimated $425K.
  • Bridgeway Capital Management first reported a position in Third Harmonic Bio in Q1 2023 and held it in 5 quarters.
  • Bridgeway Capital Management's Third Harmonic Bio position peaked at $569K in Q3 2023.
  • 76 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2024.

Based on Bridgeway Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.